What is the address of DOKTER GWENDA DELANGHE NEONATOLOGIE?

The registered office of DOKTER GWENDA DELANGHE NEONATOLOGIE is located at Korte Ridderstraat 27, 2800 Mechelen.

Is DOKTER GWENDA DELANGHE NEONATOLOGIE still active?

Yes. According to the CBE (2 October 2026) DOKTER GWENDA DELANGHE NEONATOLOGIE is active, legal situation “Normale toestand”, started on 22 September 2010.

Is DOKTER GWENDA DELANGHE NEONATOLOGIE registered on Peppol?

No, DOKTER GWENDA DELANGHE NEONATOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DOKTER GWENDA DELANGHE NEONATOLOGIE?

The enterprise number of DOKTER GWENDA DELANGHE NEONATOLOGIE is BE0829489362.

When was DOKTER GWENDA DELANGHE NEONATOLOGIE founded?

DOKTER GWENDA DELANGHE NEONATOLOGIE was founded on 22 September 2010.

Who are the directors of DOKTER GWENDA DELANGHE NEONATOLOGIE?

According to the 2025 annual accounts, the directors of DOKTER GWENDA DELANGHE NEONATOLOGIE are: Gwenda Delanghe.

Is DOKTER GWENDA DELANGHE NEONATOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 September 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER GWENDA DELANGHE NEONATOLOGIE make in 2025?

DOKTER GWENDA DELANGHE NEONATOLOGIE recorded a loss after taxes of € 20,504 in financial year 2025.

What is the revenue of DOKTER GWENDA DELANGHE NEONATOLOGIE?

As a small company, DOKTER GWENDA DELANGHE NEONATOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 4,810.

DOKTER GWENDA DELANGHE NEONATOLOGIE (Private Limited)

Dossier DOKTER GWENDA DELANGHE NEONATOLOGIE, printed on 2 October 2026 from databakkes.be/en/0829489362/dokter-gwenda-delanghe-neonatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DOKTER GWENDA DELANGHE NEONATOLOGIE from Mechelen, company number BE0829489362, closed financial year 2025 with a result of € -20,504 after tax. For that financial year DOKTER GWENDA DELANGHE NEONATOLOGIE recorded a gross margin of € 4,810 and equity of € 38,672. Compared with financial year 2024, the result moved from € -40,707 to € -20,504. The company made a loss. The buffer shrank hard: equity is 65 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What it is worth Shrank hard

€ 38,672

▼ 65% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -20,504

▲ 50 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 129,556

▼ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 26,272.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 42,710

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 165,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 273

▲ 14% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 64,474 Gross margin 2022: € 64,474 First fiscal year in the series	€ 84,778 Gross margin 2023: € 84,778 ▲ 31% vs 2022 (€ 64,474) Favourable step	€ -14,487 Gross margin 2024: € -14,487 ▼ € 99,265 vs 2023 (€ 84,778) Unfavourable step	€ 4,810 Gross margin 2025: € 4,810 ▲ € 19,297 vs 2024 (€ -14,487) Favourable step	▲ € 19,297
Profit after taxes	€ 41,604 Profit after taxes 2022: € 41,604 First fiscal year in the series	€ 43,242 Profit after taxes 2023: € 43,242 ▲ 4% vs 2022 (€ 41,604) Favourable step	€ -40,707 Profit after taxes 2024: € -40,707 ▼ € 83,949 vs 2023 (€ 43,242) Unfavourable step	€ -20,504 Profit after taxes 2025: € -20,504 ▲ € 20,203 vs 2024 (€ -40,707) Favourable step	▲ € 20,203
Equity	€ 318,556 Equity 2022: € 318,556 First fiscal year in the series	€ 361,798 Equity 2023: € 361,798 ▲ 14% vs 2022 (€ 318,556) Favourable step	€ 109,938 Equity 2024: € 109,938 ▼ 70% vs 2023 (€ 361,798) Unfavourable step	€ 38,672 Equity 2025: € 38,672 ▼ 65% vs 2024 (€ 109,938) Unfavourable step	▼ 65%
Total debts	€ 42,460 Total debts 2022: € 42,460 First fiscal year in the series	€ 12,171 Total debts 2023: € 12,171 ▼ 71% vs 2022 (€ 42,460) Favourable step	€ 147,191 Total debts 2024: € 147,191 ▲ € 135,019 vs 2023 (€ 12,171) Unfavourable step	€ 168,173 Total debts 2025: € 168,173 ▲ 14% vs 2024 (€ 147,191) Unfavourable step	▲ 14%
Cash	€ 296,722 Cash 2022: € 296,722 First fiscal year in the series	€ 228,439 Cash 2023: € 228,439 ▼ 23% vs 2022 (€ 296,722) Unfavourable step	€ 151,890 Cash 2024: € 151,890 ▼ 34% vs 2023 (€ 228,439) Unfavourable step	€ 129,556 Cash 2025: € 129,556 ▼ 15% vs 2024 (€ 151,890) Unfavourable step	▼ 15%
Land & buildings	€ 46,940 Land & buildings 2022: € 46,940 First fiscal year in the series	€ 42,705 Land & buildings 2023: € 42,705 ▼ 9% vs 2022 (€ 46,940) Unchanged	€ 38,470 Land & buildings 2024: € 38,470 ▼ 10% vs 2023 (€ 42,705) Unchanged	€ 34,235 Land & buildings 2025: € 34,235 ▼ 11% vs 2024 (€ 38,470) Unchanged	▼ 11%
Retained profit	€ 306,156 Retained profit 2022: € 306,156 First fiscal year in the series	€ 349,398 Retained profit 2023: € 349,398 ▲ 14% vs 2022 (€ 306,156) Favourable step	€ 97,538 Retained profit 2024: € 97,538 ▼ 72% vs 2023 (€ 349,398) Unfavourable step	€ 26,272 Retained profit 2025: € 26,272 ▼ 73% vs 2024 (€ 97,538) Unfavourable step	▼ 73%
Dividend	€ 71,302 Dividend 2022: € 71,302 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 71,302) Unchanged	€ 211,154 Dividend 2024: € 211,154 Unchanged (€ 0) Unchanged	€ 50,762 Dividend 2025: € 50,762 ▼ 76% vs 2024 (€ 211,154) Unchanged	▼ 76%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 165,000 Bank debt 2025: € 165,000 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 361,016 Balance sheet total 2022: € 361,016 First fiscal year in the series	€ 373,970 Balance sheet total 2023: € 373,970 ▲ 4% vs 2022 (€ 361,016) Unchanged	€ 257,128 Balance sheet total 2024: € 257,128 ▼ 31% vs 2023 (€ 373,970) Unchanged	€ 206,846 Balance sheet total 2025: € 206,846 ▼ 20% vs 2024 (€ 257,128) Unchanged	▼ 20%

Key figures of DOKTER GWENDA DELANGHE NEONATOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER GWENDA DELANGHE NEONATOLOGIE?

What happened at DOKTER GWENDA DELANGHE NEONATOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 17, 2026 New annual accounts for financial year 2025: loss of € 20,504. Source: NBB ↗
Oct 13, 2010 New establishment in Mechelen. KBO
Sep 22, 2010 Start of the company according to the CBE. KBO

In short

From € 41,604 profit in 2022 to € 20,504 loss in 2025.

Paid € 33,633 in corporate taxes since 2022.

Best year ever: 2023, with € 43,242 profit.

Paid out € 333,218 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER GWENDA DELANGHE NEONATOLOGIE? We notify you, reason included.

Follow DOKTER GWENDA DELANGHE NEONATOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Gwenda Delanghe

DOKTER GWENDA DELANGHE NEONATOLOGIE

Behind DOKTER GWENDA DELANGHE NEONATOLOGIE is Gwenda Delanghe.

See the full network in the app

Directors

According to the 2025 annual accounts

Gwenda Delanghe

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Korte Ridderstraat 27

2800 Mechelen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0829.489.362
VAT number: BE 0829.489.362
Registered office: Korte Ridderstraat 27, 2800 Mechelen
Names & denominations: DOKTER GWENDA DELANGHE NEONATOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 September 2010
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗